The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIL0A.L Regulatory News (IL0A)

  • There is currently no data for IL0A

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Stabilisation Notice

23 Jun 2022 10:03

RNS Number : 9529P
Morgan Stanley & Co. Int'l plc
23 June 2022
 

23 June 2022

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

PERMANENT TSB GROUP HOLDINGS P.L.C.

Pre-stabilisation Period Announcement

Morgan Stanley & Co. International plc (contact: Morgan Stanley Debt Syndicate - Matteo Benedetto - +44 20 7677-3409) hereby gives notice, as Coordinating Stabilisation Manager, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 and/or the UK FCA Stabilisation Binding Technical Standards.

Securities

Issuer:

PERMANENT TSB GROUP HOLDINGS P.L.C.

Guarantor(s) (if any):

N/A

Aggregate nominal amount:

To be confirmed

Description:

EUR Fixed Rate Senior Notes due 2025

Offer price:

To be confirmed

 

Stabilisation

Stabilisation Manager(s):

BofA Securities Europe SA

Citigroup Global Markets Limited

Goldman Sachs International

Morgan Stanley & Co. International plc

Stabilisation period expected to start on:

The date of this announcement

Stabilisation period expected to end no later than:

29 July 2022

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilisation Manager(s) may over-allot the securities to the extent permitted in accordance with applicable law

Stabilisation trading venue(s):

Irish Stock Exchange Regulated Market (Euronext Dublin)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

If and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with Regulation (EU) 2017/1129 (the "EEA Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the EEA Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the EEA Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

If and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK in accordance with Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation"), this announcement and the offer are only addressed to and directed at persons in the UK who are qualified investors within the meaning of the UK Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAFJMLTMTMTMBT
Date   Source Headline
1st Mar 20237:00 amRNSCommentary on 2022 Annual Financial Report
1st Mar 20237:00 amRNSAnnual Financial Report
22nd Feb 202310:00 amRNSDirectorate Change
17th Jan 202310:00 amRNSAppointment of Board Chairperson Designate
4th Jan 20234:35 pmRNSPrice Monitoring Extension
2nd Dec 20228:30 amRNSTotal Voting Rights
11th Nov 20227:00 amRNSTrading Statement
9th Nov 20224:00 pmRNSHolding(s) in Company
8th Nov 20224:55 pmRNSHolding(s) in Company
7th Nov 20227:30 amRNSUlster Bank Retail Business: Acquisition Completed
21st Sep 20224:00 pmRNSSale of Buy To Let Portfolio
4th Aug 202210:00 amRNSDirector Declaration
4th Aug 202210:00 amRNSDirectorate Change
27th Jul 20227:00 amRNSHalf-year Report
27th Jul 20227:00 amRNSCommentary on 2022 Half-Year Report
22nd Jul 20228:01 amRNSCompetition clearance received on Ulster Bank deal
13th Jul 202210:03 amRNSStabilisation Notice
24th Jun 202212:40 pmRNSResult of EGM
24th Jun 202212:40 pmRNSResult of AGM
23rd Jun 202210:03 amRNSStabilisation Notice
24th May 20225:45 pmRNSNotice of AGM
24th May 20225:45 pmRNSNotice of EGM and Publication of Circular
3rd May 20227:00 amRNSTrading Statement
28th Apr 202212:00 pmRNSDirector Declaration
31st Mar 20229:30 amRNSDirectorate Change
2nd Mar 20227:00 amRNSAnnual Financial Report
2nd Mar 20227:00 amRNSCommentary on 2021 Annual Financial Report
26th Jan 202212:00 pmRNSSuccession Plan for Board Chairman
17th Dec 20217:15 amRNSAcquisition of elements of Ulster Bank business
10th Nov 202110:00 amRNSSale of Loan Portfolio
28th Oct 20217:00 amRNSTrading Statement
28th Jul 20217:00 amRNSHalf-year Report
28th Jul 20217:00 amRNSCommentary on 2021 Half-Year Report
23rd Jul 20217:00 amRNSPotential acquisition: Certain Ulster Bank Assets
21st May 20219:48 amRNSStabilisation Notice
19th May 20213:30 pmRNSResult of AGM
12th May 20218:28 amRNSStabilisation Notice
5th May 20217:00 amRNSTrading Statement
9th Apr 202112:30 pmRNSNotice of AGM
1st Apr 20215:05 pmRNSDirector Declaration
1st Apr 20215:03 pmRNSDirector Declaration
30th Mar 202110:00 amRNSBoard Appointments
10th Mar 20218:37 amRNSMigration of Securities to Euroclear Bank
3rd Mar 20217:00 amRNSAnnual Financial Report
3rd Mar 20217:00 amRNSCommentary on 2020 Annual Financial Report
24th Feb 20217:00 amRNSRedemption of AT1 Securities
19th Feb 20217:05 amRNSStatement re: Ulster Bank Withdrawal from ROI
12th Feb 202112:11 pmRNSResult of EGM
8th Jan 202110:00 amRNSNotice of EGM
26th Nov 20203:30 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.